Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 56

Sort by

Sort Order Select

Journal Articles

Efficacy and safety of selinexor in combination with CD19/CD22 bispecific chimeric antigen receptor (CAR) T cell therapy for relapsed/refractory diffuse large B-cell lymphoma: A single-center, retrospective, real-world study

He-nan Wang, Xin-di Liu, Yuan-zheng Liang, Liang Wang, Jia Cong

Blood (2025) 146 (Supplement 1): 3715.

https://doi.org/10.1182/blood-2025-3715

Published: 2025

Journal Articles

A phase 1 study of lucar-G39D: A novel anti-CD20/CD19 dual-CAR allogeneic gamma delta T cells in adults with relapsed / refractory B-cell non-Hodgkin lymphoma (NHL)

Blood (2025) 146 (Supplement 1): 266.

https://doi.org/10.1182/blood-2025-266

Published: 2025

Journal Articles

CD19/CD22 bispecific CAR-t cell therapy for relapsed/refractory large b-cell lymphoma: A prospective, single-arm, single-center, phase 2 clinical trial

Xin-di Liu, He-nan Wang, Yuan-zheng Liang, Jia Cong, Liang Wang

Blood (2025) 146 (Supplement 1): 570.

https://doi.org/10.1182/blood-2025-570

Published: 2025

Journal Articles

Cdk6 targeting reverses leukemia in germline cebpa Q83X AML mouse model with CMP-origin transformation

Yining Li, Xuan Xiao, Junjin Lin, Jinggang Li, Huibing Yao, Yi Zheng, Na Zhang, Ning Zheng, Yixin Ma, Chenyang Zheng, Nan Wang, Xiaofan Li, Huilin Huang, Shaoyuan Wang, Nainong Li, Zhaofeng Zheng, Lili Pan

Blood (2025) 146 (Supplement 1): 985.

https://doi.org/10.1182/blood-2025-985

Published: 2025

Journal Articles

Integration of Gene Mutations in Risk Prognostication for Watch-and-Wait Follicular Lymphoma Patients Initiating First-Line Treatment

Tianyuan Xu, Nan Wang, Rui Sun, Ruichi Li, Di Fu, Yan Zhao, Pengpeng Xu, Shu Cheng, Li Wang, Wei Tang, Zhong Zheng, Weili Zhao

Blood (2024) 144 (Supplement 1): 6200.

https://doi.org/10.1182/blood-2024-204775

Published: 2024

Journal Articles

Correlation of Baseline Gene Mutations With Quizartinib Efficacy in Patients With FLT3 -ITD-Positive Newly Diagnosed Acute Myeloid Leukemia in the Phase 3 QuANTUM-First Trial

Blood (2024) 144 (Supplement 1): 848.

https://doi.org/10.1182/blood-2024-203303

Published: 2024

Journal Articles

Hematopoietic and eosinophil-specific LNK(SH2B3) deficiency promotes eosinophilia and arterial thrombosis

Huijuan Dou, Ranran Wang, Mojdeh Tavallaie, Tong Xiao, Malgorzata Olszewska, Eirini P. Papapetrou, Alan R. Tall, Nan Wang

Blood (2024) 143 (17): 1758–1772.

https://doi.org/10.1182/blood.2023021055

Published: 2024

Includes: Supplemental data

Journal Articles

Jak2 V617F clonal hematopoiesis promotes arterial thrombosis via platelet activation and cross talk

Wenli Liu, Joachim Pircher, Art Schuermans, Qurrat Ul Ain, Zhe Zhang, Michael C. Honigberg, Mustafa Yalcinkaya, Tetsushi Nakao, Ashley Pournamadri, Tong Xiao, Mohammad Ali Hajebrahimi, Lisa Wasner, David Stegner, Tobias Petzold, Pradeep Natarajan, Steffen Massberg, Alan R. Tall, Christian Schulz, Nan Wang

Blood (2024) 143 (15): 1539–1550.

https://doi.org/10.1182/blood.2023022260

Published: 2024

Includes: Multimedia, Supplemental data

Journal Articles

Novel Mouse Model That Recapitulates the Hematologic Phenotype of Diamond Blackfan Anemia

Y. Lucy Liu, Nan Wang, Nicholas Neoman, Carolyn Wong, Bertil Glader, Raymond T. Doty, Mark C Wilkes, Janis L. Abkowitz, Kathleen M. Sakamoto

Blood (2023) 142 (Supplement 1): 944.

https://doi.org/10.1182/blood-2023-187734

Published: 2023

Journal Articles

Quantum-First Trial: FMS-like Tyrosine Kinase 3-Internal Tandem Duplication ( FLT3 -ITD)-Specific Measurable Residual Disease (MRD) Clearance Assessed through Induction (IND) and Consolidation (CONS) Is Associated with Improved Overall Survival (OS) in Newly Diagnosed (nd) FLT3 -ITD+ AML Patients (pts)

Blood (2023) 142 (Supplement 1): 832.

https://doi.org/10.1182/blood-2023-186785

Published: 2023

Journal Articles

Long-Term Eltrombopag in Children with Chronic Immune Thrombocytopenia: A Single-Center Extended Real-Life Observational Study in China

Zhifa Wang, Nan Wang, Juntao Ouyang, Jingyao Ma, Man-Chiu Poon, Zhenping Chen, Xiaoling Cheng, Runhui Wu

Blood (2023) 142 (Supplement 1): 2590.

https://doi.org/10.1182/blood-2023-185812

Published: 2023

Journal Articles

Small Molecule Inhibitor Targeting Nemo-like Kinase Improves Erythropoiesis in Human and Mouse Models of Diamond Blackfan Anemia

Aya Shibuya, Lucy Liu, Mark C Wilkes, Nan Wang, Leonardo Daniels, Jayla Taylor, Bertil Glader, Kathleen M. Sakamoto

Blood (2023) 142 (Supplement 1): 2728.

https://doi.org/10.1182/blood-2023-182445

Published: 2023

Journal Articles

Clonal hematopoiesis and ischemic stroke

Nan Wang, Alan R. Tall

Blood (2023) 141 (7): 693–694.

https://doi.org/10.1182/blood.2022019177

Published: 2023

Journal Articles

Quantum-First Trial: FLT3 -ITD-Specific MRD Clearance Is Associated with Improved Overall Survival

Blood (2022) 140 (Supplement 1): 546–548.

https://doi.org/10.1182/blood-2022-162739

Published: 2022

Journal Articles

Impact of Allogeneic Hematopoietic Cell Transplantation in First Complete Remission in Addition to FLT3 Inhibition with Quizartinib in Acute Myeloid Leukemia with FLT3 -Internal Tandem Duplication: Results from the Quantum-First Trial

Blood (2022) 140 (Supplement 1): 2130–2132.

https://doi.org/10.1182/blood-2022-169011

Published: 2022

Journal Articles

Individualized Dosing of Anti-Thymocyte Globulin Led to Reduced CMV/EBV Reactivation and Superior Overall Survival in Adult Unmanipulated Haploidentical Peripheral Blood Stem Cell Transplantation: A Prospective Phase II Study

Haitao Wang, Liping Dou, Lili Wang, Bo Peng, Nan Wang, Yingxin Zhao, Jishan Du, Daihong Liu

Blood (2022) 140 (Supplement 1): 4753–4754.

https://doi.org/10.1182/blood-2022-158994

Published: 2022

Journal Articles

Addition of Ruxolitinb to Corticosteroids As First-Line Therapy for High-Risk Acute Graft Versus Host Disease in Allogeneic Peripheral Blood Stem Cell Transplantation

Liping Dou, Yanli Zhao, Lei Deng, Fang Zhou, Nan Wang, Xiangshu Jin, Fei Li, Liangding Hu, Daihong Liu

Blood (2022) 140 (Supplement 1): 1381–1382.

https://doi.org/10.1182/blood-2022-158162

Published: 2022

Journal Articles

GADD45g acts as a novel tumor suppressor, and its activation suggests new combination regimens for the treatment of AML

Dan Guo, Yangyang Zhao, Nan Wang, Na You, Wenqi Zhu, Peiwen Zhang, Qian Ren, Jing Yin, Tao Cheng, Xiaotong Ma

Blood (2021) 138 (6): 464–479.

https://doi.org/10.1182/blood.2020008229

Published: 2021

Includes: Supplemental data

Journal Articles

TWIST1 preserves hematopoietic stem cell function via the CACNA1B/Ca 2+ /mitochondria axis

Nan Wang, Jing Yin, Na You, Shangda Yang, Dan Guo, Yangyang Zhao, Yongxin Ru, Xiaoyan Liu, Hui Cheng, Qian Ren, Tao Cheng, Xiaotong Ma

Blood (2021) 137 (21): 2907–2919.

https://doi.org/10.1182/blood.2020007489

Published: 2021

Includes: Supplemental data

Journal Articles

TWIST1 Preserves Hematopoietic Stem Cell Function Via Repression of Cacna1b Expression

Nan Wang, Jing Yin, Na You, Dan Guo, Yangyang Zhao, Yongxin Ru, MD, Xiaoyan Liu, Hui Cheng, Qian Ren, Tao Cheng, Xiao-Tong Ma, PhD

Blood (2020) 136 (Supplement 1): 12.

https://doi.org/10.1182/blood-2020-139005

Published: 2020

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Efficacy and safety of selinexor in combination with CD19/CD22 bispecific chimeric antigen receptor (CAR) T cell therapy for relapsed/refractory diffuse large B-cell lymphoma: A single-center, retrospective, real-world study

A phase 1 study of lucar-G39D: A novel anti-CD20/CD19 dual-CAR allogeneic gamma delta T cells in adults with relapsed / refractory B-cell non-Hodgkin lymphoma (NHL)

CD19/CD22 bispecific CAR-t cell therapy for relapsed/refractory large b-cell lymphoma: A prospective, single-arm, single-center, phase 2 clinical trial

Cdk6 targeting reverses leukemia in germline cebpa Q83X AML mouse model with CMP-origin transformation

Integration of Gene Mutations in Risk Prognostication for Watch-and-Wait Follicular Lymphoma Patients Initiating First-Line Treatment

Correlation of Baseline Gene Mutations With Quizartinib Efficacy in Patients With FLT3 -ITD-Positive Newly Diagnosed Acute Myeloid Leukemia in the Phase 3 QuANTUM-First Trial

Hematopoietic and eosinophil-specific LNK(SH2B3) deficiency promotes eosinophilia and arterial thrombosis

Jak2 V617F clonal hematopoiesis promotes arterial thrombosis via platelet activation and cross talk

Novel Mouse Model That Recapitulates the Hematologic Phenotype of Diamond Blackfan Anemia

Long-Term Eltrombopag in Children with Chronic Immune Thrombocytopenia: A Single-Center Extended Real-Life Observational Study in China

Small Molecule Inhibitor Targeting Nemo-like Kinase Improves Erythropoiesis in Human and Mouse Models of Diamond Blackfan Anemia

Clonal hematopoiesis and ischemic stroke

Quantum-First Trial: FLT3 -ITD-Specific MRD Clearance Is Associated with Improved Overall Survival

Impact of Allogeneic Hematopoietic Cell Transplantation in First Complete Remission in Addition to FLT3 Inhibition with Quizartinib in Acute Myeloid Leukemia with FLT3 -Internal Tandem Duplication: Results from the Quantum-First Trial

Individualized Dosing of Anti-Thymocyte Globulin Led to Reduced CMV/EBV Reactivation and Superior Overall Survival in Adult Unmanipulated Haploidentical Peripheral Blood Stem Cell Transplantation: A Prospective Phase II Study

Addition of Ruxolitinb to Corticosteroids As First-Line Therapy for High-Risk Acute Graft Versus Host Disease in Allogeneic Peripheral Blood Stem Cell Transplantation

GADD45g acts as a novel tumor suppressor, and its activation suggests new combination regimens for the treatment of AML

TWIST1 preserves hematopoietic stem cell function via the CACNA1B/Ca 2+ /mitochondria axis

TWIST1 Preserves Hematopoietic Stem Cell Function Via Repression of Cacna1b Expression

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only